EXEL
Exelixis, Inc. · Healthcare
Director Stelios Papadopoulos sold $240K of Exelixis, Inc.
Sold$240,177
$21.00Price
11,437Shares
−1%Stake
What EXEL did after the filing
- The stock from Thu, May 23 open, $21.03
- +5.3%
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the Jul 9 close.
Traded Mon, May 20. Filed Wed, May 22, 7:23 PM ET, after the close. Returns use the May 23 open and the Jul 9 close. Not investment advice.